(Q34636862)

3 August 2017

1 reference

title

Continuous infusion of coagulation factors (English)

1 reference

3 August 2017

A Batorova

1

1 reference

3 August 2017

U Martinowitz

series ordinal

2

1 reference

3 August 2017

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

170-177

1 reference

Continuous intravenous infusion of factor VIII in classic haemophilia

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

The use of continuous infusion of factor concentrates in the treatment of hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Stability of factor VIII concentrates after reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

The feasibility of using concentrates containing factor IX for continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Continuous infusion of FVIII and FIX concentrates: in vitro analysis of clinically relevant parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Evaluation of recombinant factor VIII (Kogenate) stability for continuous infusion using a minipump infusion device

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Recombinant factor IX (BeneFix) by adjusted continuous infusion: a study of stability, sterility and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring, and cost effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Continuous infusion of monoclonal antibody-purified factor VIII: rational approach to serious hemorrhage in patients with allo-/autoantibodies to factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Continuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Safety and efficacy of high-purity concentrates in haemophiliac patients undergoing surgery by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Liver failure and mortality in HIV-positive haemophiliacs: FOURTEEN-YEAR EXPERIENCE AND LITERATURE REVIEW.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Treatment with a pure factor IX concentrate in a patient with moderate hemophilia B undergoing bilateral total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Efficacy and safety of continuous infusion of Mononine during five surgical procedures in three hemophilic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

The pharmacokinetics of factor VIII and factor IX: methodology, pitfalls and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Dosing and monitoring NovoSeven treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

Homozygosity for R87H missense mutation and for a rare intron 7 DNA variant (7054G --> A) in the PROC genes of three siblings initially classified as heterozygotes for protein C deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00635.X

10.1046/J.1365-2516.2002.00635.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference